These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1802685

  • 21. [Cushing's syndrome: diagnostic exploration].
    Tabarin A, Roger P.
    Presse Med; ; 23(1):43-8. PubMed ID: 8127815
    [Abstract] [Full Text] [Related]

  • 22. Cushing's syndrome. Screening methods in hospitalized patients.
    Dunlap NE, Grizzle WE, Siegel AL.
    Arch Pathol Lab Med; 1985 Mar; 109(3):222-9. PubMed ID: 3838451
    [Abstract] [Full Text] [Related]

  • 23. Overnight dexamethasone suppression test: a reliable screen for Cushing's syndrome in the obese.
    Ness-Abramof R, Nabriski D, Apovian CM, Niven M, Weiss E, Shapiro MS, Shenkman L.
    Obes Res; 2002 Dec; 10(12):1217-21. PubMed ID: 12490665
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Food-dependent Cushing's syndrome mediated by aberrant adrenal sensitivity to gastric inhibitory polypeptide.
    Reznik Y, Allali-Zerah V, Chayvialle JA, Leroyer R, Leymarie P, Travert G, Lebrethon MC, Budi I, Balliere AM, Mahoudeau J.
    N Engl J Med; 1992 Oct 01; 327(14):981-6. PubMed ID: 1325609
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. A very high dose dexamethasone suppression test for differential diagnosis of Cushing's syndrome.
    al-Saadi N, Diederich S, Oelkers W.
    Clin Endocrinol (Oxf); 1998 Jan 01; 48(1):45-51. PubMed ID: 9509067
    [Abstract] [Full Text] [Related]

  • 29. The superiority of the metyrapone test versus the high-dose dexamethasone test in the differential diagnosis of Cushing's syndrome.
    Sindler BH, Griffing GT, Melby JC.
    Am J Med; 1983 Apr 01; 74(4):657-62. PubMed ID: 6837591
    [Abstract] [Full Text] [Related]

  • 30. The diagnostic value of late-night salivary cortisol for diagnosis of subclinical Cushing's syndrome.
    Kuzu I, Zuhur SS, Demir N, Aktas G, Yener Ozturk F, Altuntas Y.
    Endokrynol Pol; 2016 Apr 01; 67(5):487-492. PubMed ID: 26884297
    [Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Overnight dexamethasone suppression test: normal responses and the diagnosis of Cushing's syndrome.
    Blethen SL, Chasalow FI.
    Steroids; 1989 Aug 01; 54(2):185-93. PubMed ID: 2588297
    [Abstract] [Full Text] [Related]

  • 39. A reappraisal of the ovine corticotropin-releasing hormone stimulation test in the differential diagnosis of Cushing's syndrome: a comparison with the standard high-dose dexamethasone suppression test.
    Lee TI, Lin SY, Won JG, Tang KT, Jap TS, Kwok CF, Lin HD.
    Zhonghua Yi Xue Za Zhi (Taipei); 2002 Oct 01; 65(10):474-82. PubMed ID: 12523812
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 10.